Articles Tagged With: vaccines
-
Form Follows Function — Structure-Based Vaccines Make Progress Against RSV
In older patients who are at risk for severe disease caused by respiratory syncytial virus (RSV), two new distinct vaccine candidates based on the stabilized prefusion F protein demonstrated efficacy and prevented RSV lower respiratory tract disease in patients older than age 60 years.
-
2022-2023: A Severe Season for Respiratory Syncytial Virus
The 2022-2023 northern hemisphere respiratory syncytial virus (RSV) season began with fury, crowding hospitals and making many young children extremely ill. Meanwhile, advancing research points to potential means of better preventing RSV infection.
-
Lessons Learned, Initiatives to Support
Conceding that the pandemic has undone much of the nation’s progress on preventing the rise of antimicrobial resistance, especially in hospitals, the Centers for Disease Control and Prevention urged support and funding for key initiatives.
-
Kindergarten Vaccine Rates: Post-COVID
The COVID-19 pandemic caused disruption in healthcare delivery for everyone. Schools continue to struggle to meet the Healthy People 2030 Nationwide target of ≥ 95% coverage for measles, mumps, rubella (MMR) vaccination in kindergarteners, and COVID-19 did not help. Remarkably, the nationwide vaccine rate for children entering kindergarten in the 2020-2021 school year was decreased by only 1% for all vaccines compared with the previous year.
-
Safety of Infliximab After Live Vaccines
Despite concerns about the use of infliximab for children with Kawasaki disease shortly after administration of live vaccines, retrospective reviews do not show any vaccine-related infections following subsequent infliximab use.
-
WHO Cooperative Treaty for Next Pandemic Begins in Controversy
The World Health Organization is continuing discussions of an international treaty or framework for global cooperation during the next pandemic, but the effort may struggle to gain traction in a divided, highly politicized environment currently holding sway in the United States.
-
Too Many Antibiotics May Affect Vaccine Response Among Infants, Toddlers
Remain cautious about overprescribing antibiotics.
-
Vaccine Expert: SARS-CoV-2 Is Becoming Endemic
Make of it what you will in an unpredictable pandemic, but one of the nation’s leading vaccine and immunology experts sees COVID-19 fading to a somewhat undefined endemic level and then returning as a seasonal virus next winter. -
Omicron: Get Your Booster Dose!
While vaccination provides protection against the omicron variant of SARS-CoV-2, high-level protection from a need for hospitalization requires receipt of a booster dose.
-
An Epidemic of Long COVID May Be the Legacy of Omicron
The loosening of COVID-19 policies and shortening duration of precautions signal the emergence of what some call the “inevitability camp”: those who believe everyone will contract the rapidly spreading omicron variant, thereby generating herd immunity. There is one major problem with this view. It is becoming increasingly apparent that 14% (estimated range 2%-30%) of those infected with omicron will develop long COVID, a prolonged set of neurological and physical maladies that have haunted some people since the pandemic began in 2020.